Ranibizumab 0.5 mg for Diabetic Macular Edema With Initial Intensive Treatment in the Real World Clinical Setting in Korea (Rising K)
Clinical trial NCT05815212 · COMPLETED
Trial details
- NCT number
- NCT05815212
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-11
- Primary completion
- 2022-04-04
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.